Incentivizing treatment for opioid and stimulant use disorders in primary care
Official title: Contingency Management as a Treatment for Opioid Use Disorder and Stimulant Use Disorder in a Primary Care Setting
Run by University of Minnesota · NCT05288751 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing a program that gives patients money for attending appointments and staying off drugs to see if it helps them stick with their treatment for opioid and stimulant use disorders.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 42 (estimated) |
| Sponsor | University of Minnesota Academic / other |
| Locations | 1 site (Minneapolis, Minnesota) |
| Trial ID | NCT05288751 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with a diagnosis of opioid use disorder and/or stimulant use disorder who have recently started medications for opioid use disorder.
✕Probably not a fit
Patients with cognitive impairments or those prescribed amphetamines may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study implements a contingency management (CM) program aimed at patients with opioid use disorder, with or without stimulant use disorder, who are starting outpatient addiction medicine services. Participants will receive monetary incentives for attending appointments and for abstaining from substance use, as measured by urine toxicology screens. The goal is to enhance patient engagement and retention in treatment programs within a primary care setting. Data collected will help improve treatment outcomes for individuals receiving medications for opioid use disorder.
Why it matters
Potential benefit: If successful, this approach could significantly improve treatment adherence and outcomes for patients with opioid and stimulant use disorders.
How similar studies have gone: Previous studies have shown that contingency management can be effective in treating substance use disorders, indicating potential success for this approach in primary care settings.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * At least 18 years of age * Diagnosis of Opioid Use Disorder and/or Stimulant Use Disorder * Recently initiated medications for opioid use disorder (MOUDs) at Broadway Family Medicine (BFM), within 2 weeks of recruitment * Have an active prescription for buprenorphine-naloxone (Suboxone) Exclusion Criteria: * Prescription for an amphetamine would exclude patients from the abstinence-based CM, but they could participate in the attendance-only CM. * Dementia, development disabilities, or cognitive functioning that is too low to participate in study measures, as determined by chart review and consultation with overseeing physician.
Where it's running
-
University of Minnesota
Minneapolis, Minnesota, United States Recruiting
Study contacts
- Principal investigator: Robert Levy, MD — University of Minnesota
- Study coordinator: Mary Lonergan-Cullum, PhD
- Email: loner026@umn.edu
- Phone: 612-302-8263
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Integrated care for hospitalized patients with opioid and stimulant use disorders and infections
This study tests if a new combined care approach for patients with infections from using opioids or stimulants can help them stay healthier and avoid going back to the hospital compared to regular treatment.
-
CBD for Opioid Dependence and Pain on Buprenorphine
This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.
-
Cebranopadol for opioid withdrawal in adults with chronic pain
This study tests whether cebranopadol can reduce withdrawal symptoms in adults with chronic pain who are physically dependent on prescribed opioids, compared with placebo.
-
emPath platform pilot to link and keep adults with opioid use disorder in care in Durham
This pilot tests a mobile app and telemedicine approach to help adults with opioid use disorder start and stay in MOUD through community outreach in Durham, NC.
-
CB1 Receptors in Opioid Use Disorder Measured with a PET Radioligand
This study tests CB1 receptor availability in people with opioid use disorder starting opioid agonist therapy and compares them with healthy adults.
-
STORC: Training a support person plus patient navigation after birth
We’re testing whether training a designated support person and using patient navigation after delivery helps people with opioid use disorder build recovery resources and stay in treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.